Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation ...

PARIS, FRANCE, 8 avril 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd’hui que son Document d’enregistrement universel 2024 a été déposé le 7 avril 2025 auprès de l’Autorité des Marchés ...

PARIS, FRANCE, 8 April 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the filing of its 2024 Universal Registration Document with the French Autorité des Marchés Financiers (AMF) on 7 April ...

Note: alfa pump® and DSR® are registered trademarks.

Avadel has initiated four patent infringement lawsuits against Jazz Pharmaceuticals since the beginning of 2025, alleging certain uses of Jazz’s Xywav product, according to its corresponding labeling, ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, proudly announces its role as a Silver Sponsor at the World Orphan Drug Congress USA ...

CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for neurodegenerative diseases characterized by ...

Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and ...

ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 ...

We are excited to welcome Abid to our executive team,” said Jeff Glazier, Chief Executive Officer of General Oncology. “With deep expertise in strategic financial leadership, capital raising, and ...

PriceDynamix is one of several solutions AMPS has developed to challenge outdated models and provide a more effective, transparent way to manage healthcare costs. AMPS empowers organizations to ...